Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?
Klaassen Z, Singh AA, Howard LE, Feng Z, Trock B, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ, Partin A, Han M, Freedland SJ.
Klaassen Z, et al. Among authors: howard le.
Cancer. 2015 May 1;121(9):1414-21. doi: 10.1002/cncr.29147. Epub 2014 Dec 9.
Cancer. 2015.
PMID: 25492369
Free PMC article.